The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data;VL Gordon-Dseagu;Int J Epidemiol,2018
2. Treatment options for advanced pancreatic cancer: a review;R Warsame;Expert Rev Anticancer Ther,2012
3. Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations;S Guo;World J Clin Oncol,2017
4. Validating survivin as a cancer therapeutic target;DC Altieri;Nat Rev Cancer,2003
5. Association of survivin splice variants with prognosis and treatment of breast cancer;A Pavlidou;World J Clin Oncol,2014
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review;Frontiers in Bioscience-Landmark;2024-08-22
2. A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT;Journal of Materials Chemistry B;2024
3. Immune modulators for pancreatic ductal adenocarcinoma therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024
4. Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective;Journal of Medicinal Chemistry;2023-12-13
5. Identification of Potential Biomarkers associated with Prognosis and Pathogenesis of Pancreatic Cancer;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3